Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Navigate

Research Leaders

8 sponsors active, led by Health Sciences North

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT03919760Not ApplicableCompleted

Early Psychosis Intervention - Spreading Evidence-based Treatment

Showing all 1 trials

Research Network

Common Treatments

  • Navigate1
  • Treatment As Usual1

Active Sponsors

  • Health Sciences North1
  • Niagara Region Public Health1
  • Canadian Mental Health Association1
  • Lakeridge Health Corporation1
  • Centre for Addiction and Mental Health1

Top Investigators

Related Conditions

  • Psychosis1
  • Schizophrenia Spectrum And Other Psychotic Disorders1
  • First Episode Psychosis1
  • Schizophreniform Disorders1
  • Schizoaffective Disorder1

Activity Timeline